Recommendations for Diagnosis and Prevention of Cytomegalovirus-Associated Necrotizing Enterocolitis in Breast-Fed

Jennifer T Pham1, Allison F Dahlgren2, Phornphat Rasamimari3

  • 1Department of Pharmacy Practice (JTP), University of Illinois at Chicago College of Pharmacy, University of Illinois Hospital & Health Sciences System, Chicago, IL.

Insights

Cytomegalovirus (CMV) infection in a preterm infant caused severe necrotizing enterocolitis (NEC) and thrombocytopenia. Ganciclovir treatment led to significant clinical improvement, highlighting its potential in managing these severe infant complications.

Area of Science:

  • Neonatal Medicine
  • Pediatric Infectious Diseases
  • Gastroenterology

Background:

  • Postnatally acquired cytomegalovirus (CMV) can cause severe complications in preterm infants.
  • Necrotizing enterocolitis (NEC) is a serious gastrointestinal emergency in neonates.
  • CMV infection is an underrecognized cause of NEC and other GI issues in infants.

Purpose of the Study:

  • To report a case of severe necrotizing enterocolitis and thrombocytopenia in a preterm infant due to cytomegalovirus.
  • To review the literature on cytomegalovirus-related gastrointestinal complications in infants.
  • To highlight the efficacy of ganciclovir in treating CMV-associated NEC.

Main Methods:

  • Case presentation of a preterm infant with CMV infection, NEC, and thrombocytopenia.
  • Administration of intravenous ganciclovir upon CMV diagnosis.
  • Comprehensive literature review of CMV-related gastrointestinal disease in neonates and infants.

Main Results:

  • The infant experienced severe thrombocytopenia and clinical deterioration unresponsive to transfusions.
  • Intravenous ganciclovir treatment resulted in significant clinical improvement.
  • Literature review identified other cases of CMV-associated NEC and GI complications.

Conclusions:

  • Cytomegalovirus should be considered in the differential diagnosis of severe NEC and thrombocytopenia in preterm infants.
  • Ganciclovir is an effective treatment for cytomegalovirus-related gastrointestinal disease in infants.
  • Early diagnosis and treatment of CMV are crucial for improving outcomes in affected neonates.